Cox regression analysis showed that a loss of HER2 expression from primary BC to the first relapse correlated significantly with a better OS (hazard ratio 0.533, 95% CI 0.32–0.90, p = 0.018). This evidence concerns the gene ERBB2 and breast cancer.